Hutson Nancy J
Insider CIK 1379222 · ENDP Director · PHAS Director · CLSD Director · ENDP Director · BCRX Director · CBST Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2025-06-12 | 2025-06-16 | 27,181 | — | $0 | 27,181 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2025-06-12 | 2025-06-16 | 12,500 | — | $0 | 99,138 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2024-12-13 | 2024-12-16 | 7,000 | $7.54 | $52.8K | 86,638 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2024-06-12 | 2024-06-14 | 49,933 | — | $0 | 49,933 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2024-06-12 | 2024-06-14 | 6,820 | — | $0 | 93,638 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2024-05-20 | 2024-05-22 | 5,000 | $6.38 | $31.9K | 86,818 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2023-10-03 | 2023-10-04 | 10,000 | $0.86 | $8.6K | 93,000 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2023-06-14 | 2023-06-15 | 12,866 | $8.04 | $103.4K | 81,818 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2023-06-13 | 2023-06-15 | 39,072 | — | $0 | 39,072 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-06-13 | 2023-06-15 | 16,745 | — | $0 | 94,684 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2023-05-19 | 2023-05-19 | 3,750 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2023-05-19 | 2023-05-19 | 3,750 | — | $0 | 37,510 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2022-11-17 | 2022-11-21 | 30,000 | $1.33 | $39.9K | 83,000 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2022-06-07 | 2022-06-09 | 30,022 | — | $0 | 30,022 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-06-07 | 2022-06-09 | 12,866 | — | $0 | 77,939 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-05-19 | 2022-05-20 | 3,750 | — | $0 | 3,750 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-05-19 | 2022-05-20 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2021-11-08 | 2021-11-08 | 7,400 | $3.15 | $23.3K | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2021-11-08 | 2021-11-08 | 7,400 | $3.15 | $23.3K | 33,760 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2021-11-05 | 2021-11-08 | 24,860 | $2.26 | $56.2K | 2,256 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2021-11-05 | 2021-11-08 | 1,500 | $3.15 | $4.7K | 7,400 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2021-11-05 | 2021-11-08 | 24,860 | $2.26 | $56.2K | 24,860 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2021-11-05 | 2021-11-08 | 1,500 | $3.15 | $4.7K | 26,360 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | M Exercise deriv | 2021-10-29 | 2021-11-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | M Exercise deriv | 2021-10-29 | 2021-11-02 | 25,000 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | M Exercise | 2021-10-29 | 2021-11-02 | 25,000 | $2.00 | $50.0K | 38,000 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | M Exercise | 2021-10-29 | 2021-11-02 | 15,000 | $2.09 | $31.3K | 53,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-10-15 | 2021-10-19 | 30,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-10-15 | 2021-10-19 | 30,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-10-15 | 2021-10-19 | 30,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-10-15 | 2021-10-19 | 15,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2021-10-15 | 2021-10-19 | 105,000 | $15.40 | $1.62M | 65,073 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-10-15 | 2021-10-19 | 30,000 | $3.22 | $96.6K | 170,073 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-10-15 | 2021-10-19 | 15,000 | $1.71 | $25.6K | 140,073 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-10-15 | 2021-10-19 | 30,000 | $5.13 | $153.9K | 125,073 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-10-15 | 2021-10-19 | 30,000 | $2.91 | $87.3K | 95,073 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2021-08-18 | 2022-05-20 | 3,000 | $3.08 | $9.2K | 4,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2021-08-18 | 2021-08-19 | 3,000 | $3.08 | $9.2K | 4,000 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2021-08-16 | 2021-08-17 | 3,000 | $5.68 | $17.0K | 13,000 | SEC↗ |
| ENDP Endo International plc | A Award | 2021-06-11 | 2021-06-15 | 47,924 | — | $0 | 139,143 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2021-06-11 | 2021-06-15 | 23,003 | $6.26 | $144.0K | 116,140 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2021-06-10 | 2021-06-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-06-10 | 2021-06-14 | 15,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-06-10 | 2021-06-14 | 8,333 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-06-10 | 2021-06-14 | 8,333 | $2.85 | $23.7K | 73,406 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-06-10 | 2021-06-14 | 15,000 | $3.32 | $49.8K | 88,406 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2021-06-10 | 2021-06-14 | 23,333 | $16.86 | $393.4K | 65,073 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2021-06-03 | 2021-06-04 | 14,000 | — | $0 | 14,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-05-28 | 2021-06-01 | 317 | $15.77 | $5.0K | 65,073 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2021-05-25 | 2021-05-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2021-03-12 | 2021-03-15 | 5,000 | $3.11 | $15.6K | 10,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-02-26 | 2021-03-02 | 463 | $10.78 | $5.0K | 64,756 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2020-11-30 | 2020-12-02 | 978 | $5.11 | $5.0K | 64,293 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2020-08-31 | 2020-09-02 | 1,204 | $4.15 | $5.0K | 63,315 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2020-06-12 | 2020-06-16 | 12,245 | $3.43 | $42.0K | 91,219 | SEC↗ |
| ENDP Endo International plc | A Award | 2020-06-12 | 2020-06-16 | 25,511 | — | $0 | 103,464 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2020-06-03 | 2020-06-05 | 16,000 | — | $0 | 16,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2020-06-01 | 2020-06-03 | 2,224 | $4.50 | $10.0K | 62,111 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2020-05-20 | 2020-05-21 | 5,000 | $1.85 | $9.3K | 5,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-05-12 | 2020-05-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2020-04-21 | 2020-04-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2020-03-01 | 2020-03-03 | 3,333 | $3.00 | $10.0K | 59,887 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2019-12-01 | 2019-12-03 | 3,508 | $2.85 | $10.0K | 56,554 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2019-11-18 | 2019-11-18 | 10,000 | $1.45 | $14.5K | 53,046 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2019-09-01 | 2019-09-04 | 3,344 | $2.99 | $10.0K | 43,046 | SEC↗ |
| ENDP Endo International plc | A Award | 2019-06-12 | 2019-06-14 | 53,812 | — | $0 | 103,782 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2019-06-12 | 2019-06-14 | 25,829 | $4.46 | $115.2K | 77,953 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2019-05-29 | 2019-05-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2019-05-09 | 2019-05-13 | 11,000 | — | $0 | 11,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2019-02-27 | 2019-03-01 | 8,900 | — | $0 | 8,900 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-12-17 | 2018-12-17 | 1,000 | $4.46 | $4.5K | 1,000 | SEC↗ |
| ENDP Endo International plc | S Sale | 2018-11-15 | 2018-11-16 | 10,000 | $12.83 | $128.3K | 49,970 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2018-06-20 | 2018-06-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2018-06-08 | 2018-06-12 | 15,019 | $7.67 | $115.2K | 59,970 | SEC↗ |
| ENDP Endo International plc | A Award | 2018-06-08 | 2018-06-12 | 31,291 | — | $0 | 74,989 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2018-06-01 | 2018-06-04 | 1,555 | $6.43 | $10.0K | 39,702 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2018-03-01 | 2018-03-02 | 2,012 | $4.97 | $10.0K | 38,147 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2017-12-01 | 2017-12-04 | 1,968 | $5.08 | $10.0K | 36,135 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2017-09-01 | 2017-09-05 | 1,960 | $5.10 | $10.0K | 34,167 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2017-06-09 | 2017-06-12 | 11,488 | $11.49 | $132.0K | 43,698 | SEC↗ |
| ENDP Endo International plc | A Award | 2017-06-09 | 2017-06-12 | 23,934 | — | $0 | 55,186 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2017-06-01 | 2017-06-02 | 1,941 | $5.15 | $10.0K | 32,207 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-05-24 | 2017-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ENDP Endo International plc | S Sale | 2017-03-09 | 2017-03-10 | 5,325 | $10.82 | $57.6K | 31,252 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2017-03-01 | 2017-03-02 | 1,602 | $6.24 | $10.0K | 30,266 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2016-12-01 | 2016-12-02 | 1,788 | $5.59 | $10.0K | 28,664 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2016-09-01 | 2016-09-06 | 2,433 | $4.11 | $10.0K | 26,876 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2016-05-31 | 2016-06-02 | 2,581 | $3.39 | $8.7K | 24,443 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2016-05-23 | 2016-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ENDP Endo International plc | A Award | 2016-03-01 | 2016-03-03 | 7,111 | — | $0 | 39,990 | SEC↗ |
| ENDP Endo International plc | S Sale | 2016-03-01 | 2016-03-03 | 3,413 | $42.19 | $144.0K | 36,577 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2016-02-29 | 2016-03-01 | 4,396 | $1.99 | $8.7K | 21,862 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2015-11-30 | 2015-12-03 | 824 | $10.61 | $8.7K | 17,466 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2015-08-31 | 2015-09-02 | 751 | $11.64 | $8.7K | 16,642 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-05-20 | 2015-05-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ENDP Endo International plc | A Award | 2015-03-04 | 2015-03-06 | 3,436 | — | $0 | 32,879 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2015-02-20 | 2015-02-23 | 10,000 | $10.27 | $102.7K | 15,891 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 16,519 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 9,472 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 9,367 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 8,370 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 1,687 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | D To issuer deriv | 2015-01-21 | 2015-01-21 | 6,202 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2015-01-21 | 2015-01-21 | 5,951 | $102.00 | $607.0K | 0 | SEC↗ |
| ENDP Endo International plc | A Award | 2014-09-08 | 2014-09-10 | 2,445 | — | $0 | 29,443 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-08-18 | 2014-08-18 | 9,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-08-18 | 2014-08-18 | 9,000 | — | $0 | 14,951 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2014-08-18 | 2014-08-18 | 9,000 | $65.00 | $585.0K | 5,951 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2014-06-03 | 2014-06-05 | 1,687 | — | $0 | 1,687 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2014-06-03 | 2014-06-05 | 1,104 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2014-06-03 | 2014-06-05 | 6,202 | — | $0 | 6,202 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2014-06-03 | 2014-06-05 | 1,104 | — | $0 | 5,951 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-05-02 | 2014-05-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ENDP Endo International plc | M Exercise deriv | 2014-03-10 | 2014-03-11 | 5,000 | — | $0 | 5,091 | SEC↗ |
| ENDP Endo International plc | S Sale | 2014-03-10 | 2014-03-11 | 5,000 | $72.12 | $360.6K | 20,483 | SEC↗ |
| ENDP Endo International plc | M Exercise | 2014-03-10 | 2014-03-11 | 5,000 | $17.27 | $86.3K | 25,483 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | D To issuer deriv | 2014-02-28 | 2014-03-03 | 8,094 | — | $0 | 0 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | D To issuer deriv | 2014-02-28 | 2014-03-03 | 10,091 | — | $0 | 0 | SEC↗ |
| ENDP Endo International plc | A Award deriv | 2014-02-28 | 2014-03-04 | 10,091 | — | $0 | 10,091 | SEC↗ |
| ENDP Endo International plc | A Award deriv | 2014-02-28 | 2014-03-04 | 8,094 | — | $0 | 8,094 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | D To issuer | 2014-02-28 | 2014-03-03 | 6,515 | — | $0 | 0 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | D To issuer | 2014-02-28 | 2014-03-03 | 20,483 | — | $0 | 0 | SEC↗ |
| ENDP Endo International plc | A Award | 2014-02-28 | 2014-03-04 | 6,515 | — | $0 | 6,515 | SEC↗ |
| ENDP Endo International plc | A Award | 2014-02-28 | 2014-03-04 | 20,483 | — | $0 | 20,483 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-07-26 | 2013-07-29 | 5,000 | — | $0 | 9,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-07-26 | 2013-07-29 | 5,000 | $18.22 | $91.1K | 9,847 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-07-26 | 2013-07-29 | 5,000 | $53.87 | $269.4K | 4,847 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2013-06-12 | 2013-06-14 | 1,104 | — | $0 | 1,104 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2013-06-12 | 2013-06-14 | 8,370 | — | $0 | 8,370 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-06-06 | 2013-06-11 | 1,347 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-06-06 | 2013-06-11 | 1,347 | — | $0 | 4,847 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2013-05-31 | 2013-06-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-04-26 | 2013-04-26 | 5,000 | — | $0 | 14,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-04-26 | 2013-04-26 | 5,000 | $46.23 | $231.1K | 3,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-04-26 | 2013-04-26 | 5,000 | $18.22 | $91.1K | 8,500 | SEC↗ |
| ENDP ENDO HEALTH SOLUTIONS INC. | A Award | 2013-03-12 | 2013-03-14 | 6,515 | — | $0 | 6,515 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2013-01-28 | 2013-01-30 | 5,000 | — | $0 | 0 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2013-01-28 | 2013-01-30 | 5,000 | $17.95 | $89.8K | 8,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2013-01-28 | 2013-01-30 | 5,000 | $43.27 | $216.4K | 3,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-10-26 | 2012-10-30 | 5,000 | — | $0 | 5,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-10-26 | 2012-10-30 | 5,000 | $17.95 | $89.8K | 8,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2012-10-26 | 2012-10-30 | 5,000 | $43.52 | $217.6K | 3,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2012-06-06 | 2012-06-11 | 9,367 | — | $0 | 9,367 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2012-06-06 | 2012-06-11 | 1,347 | — | $0 | 1,347 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2012-05-23 | 2012-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ENDP ENDO PHARMACEUTICALS HOLDI | M Exercise deriv | 2012-03-12 | 2012-03-14 | 1,417 | — | $0 | 0 | SEC↗ |
| ENDP ENDO PHARMACEUTICALS HOLDI | M Exercise | 2012-03-12 | 2012-03-14 | 1,417 | — | $0 | 19,483 | SEC↗ |
| ENDP ENDO PHARMACEUTICALS HOLDI | A Award | 2012-03-12 | 2012-03-14 | 5,481 | — | $0 | 5,481 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2012-01-20 | 2012-01-23 | 8,333 | — | $0 | 8,333 | SEC↗ |